EGFR and cancer: In addition to the suppression of acute inflammation after UV exposure documented here, abrogation of EGFR function is also well known to lead to cutaneous inflammation, more specifically to folliculitis, in cancer patients undergoing longer-term treatment with EGFR inhibitors [44].